Serina Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Huntsville, AL
SEC filing record 1 source field available
Fiscal year end
31 December
Serina Therapeutics, Inc. has filed 508 SEC EDGAR filings since 10 Jul 2017

SEC filing history

Showing 476-500 of 508 matching filings.

Per page
25
Current page
20
5

FORM 5 SUBMISSION

Filing date
14 Feb 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
14 Feb 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
14 Feb 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
14 Feb 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90737

SCHEDULE 13G

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90737

SCHEDULE 13G

Filing date
12 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-229432

S-8 filing

Filing date
30 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Dec 2018
Reporting date
10 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90737

SC 13G filing

Filing date
10 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38519

AGEX THERAPEUTICS, INC. 8-K

Filing date
29 Nov 2018
Reporting date
29 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
28 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-38519

CT ORDER filing

Filing date
28 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF ACTION

SEC STAFF ACTION filing

Filing date
27 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-38519

NYSE CERTIFICATION AGEX THERAPEUTICS, INC.

Filing date
27 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12B/A File 001-38519

10-12B/A filing

Filing date
26 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12B/A File 001-38519

10-12B/A filing

Filing date
05 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .